share_log

Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Duncan Barbara Gayle

SEC ·  Feb 26, 2024 17:57
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more